DATA SHEET - Medsafe
VIREAD Data Sheet (14 July 2017) 2 of 46 illnesses or the need for treatment with other medicinal products concomitantly with VIREAD should be taken into consideration.
Download DATA SHEET - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
South Carolina Department of Health and Human Services ...
southcarolina.fhsc.comEpclusa ® Mavyret ™ Vosevi® Class level PA is in effect for this class. Once criteria are met, the agents listed on the PDL are includes Metavir F0-F4.
AIDS DESCOVY InfoNet www.aidsinfonet.org Fact Sheet …
www.aidsinfonet.orgA Project of the International Association of Providers of AIDS Care. Fact Sheets can be downloaded from the Internet at http://www.aidsinfonet.org
PRODUCT MONOGRAPH INCLUDING PATIENT …
www.gilead.caPRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrVIREAD (tenofovir disoproxil fumarate) tablets . 300 mg . Antiretroviral Agent . Gilead Sciences, Inc.
Hepatitis B Foundation Cause for a Cure
www.hepb.orgLiving With Hepatitis B What is hepatitis B? Hepatitis B is the world’s most common liver infection. It is caused by the hepatitis B virus (HBV), which can attack and injure the liver.
NEW ZEALAND DATA SHEET (TENOFOVIR DISOPROXIL …
www.medsafe.govt.nzTRUVADA must not be administered to children or adolescents under the age of 18 years. TRUVADA is a fixed-dose combination of tenofovir disoproxil fumarate and emtricitabine.
Prescription Drug Listing - horizonnjhealth.com
www.horizonnjhealth.comVitamin A derivatives are considered noncovered pharmacy benefits for members 35 years of age and older.